FDA Makes Available Summaries of Pediatric Studies for Various Medications

Summary

The Food and Drug Administration (FDA) has released summaries of medical and clinical pharmacology reviews of pediatric studies for several medications, including PARAPLATIN, TRUSOPT, and ZOLOFT, as required by the Best Pharmaceuticals for Children Act (BPCA). The summaries are also available for antidepressants such as CELAXA, REMERON, and SERZONE, which were submitted before the BPCA was implemented.